PBS updates

Xeomin (IncobotulinumtoxinA)

incobotulinumtoxinA 100 units injection, 1 vial · INJECTION · PBS code 15226J

STREAMLINED

What it costs

AU$317.7 PBS-determined price per 1 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2026-03-01.
  • • Repeats: 0.
  • • PBS program: MF.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Chronic sialorrhea


Patient must be initiating treatment with a Drooling Severity and Frequency Scale (DSFS) score of at least 6; or

Patient must be continuing treatment with improvement in the DSFS score of at least 1 point from baseline as assessed by the treating clinician; AND

Patient must have cerebral palsy; or

Patient must have traumatic brain injury; or

Patient must have developmental disorder; AND

Patient must be aged from 2 to 17 years inclusive; AND

Must be treated by a neurologist; or

Must be treated by a rehabilitation specialist; or

Must be treated by a paediatrician; or

Must be treated by an otolaryngologist surgeon; or

Must be treated by a plastic surgeon.

Sponsor: Encapsulate Pharma Pty Ltd ABN 80 640 718 289

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.